Two Sigma Advisers’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.89M | Sell |
|
|||||
|
2025
Q1 | $5.1M | Sell |
|
|||||
|
2024
Q4 | $35.9M | Buy |
|
|||||
|
2024
Q3 | $18.6M | Buy |
|
|||||
|
2024
Q2 | $14.6M | Sell |
|
|||||
|
2024
Q1 | $13.4M | Sell |
|
|||||
|
2023
Q4 | $10.6M | Sell |
|
|||||
|
2023
Q3 | $10.6M | Sell |
|
|||||
|
2023
Q2 | $9.59M | Sell |
|
|||||
|
2023
Q1 | $12.8M | Sell |
|
|||||
|
2022
Q4 | $23.4M | Sell |
|
|||||
|
2022
Q3 | $21.8M | Buy |
|
|||||
|
2022
Q2 | $10.2M | Sell |
|
|||||
|
2022
Q1 | $13.7M | Buy |
|
|||||
|
2021
Q4 | $10.9M | Buy |
|
|||||
|
2021
Q3 | $2.26M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $3.85M | Sell |
|
|||||
|
2020
Q4 | $4.8M | Sell |
|
|||||
|
2020
Q3 | $6.68M | Sell |
|
|||||
|
2020
Q2 | $12.6M | Sell |
|
|||||
|
2020
Q1 | $18.5M | Buy |
|
|||||
|
2019
Q4 | $11.3M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $3.05M | Buy |
|
|||||
|
2018
Q4 | $2.65M | Sell |
|
|||||
|
2018
Q3 | $7.86M | Sell |
|
|||||
|
2018
Q2 | $81.9M | Sell |
|
|||||
|
2018
Q1 | $66.2M | Sell |
|
|||||
|
2017
Q4 | $118M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $4.04M | Sell |
|
|||||
|
2017
Q1 | $148M | Buy |
|
|||||
|
2016
Q4 | $137M | Buy |
|
|||||
|
2016
Q3 | $42.2M | Sell |
|
|||||
|
2016
Q2 | $119M | Buy |
|
|||||
|
2016
Q1 | $79.5M | Buy |
|
|||||
|
2015
Q4 | $8.62M | Sell |
|
|||||
|
2015
Q3 | $76M | Sell |
|
|||||
|
2015
Q2 | $83.4M | Buy |
|
|||||
|
2015
Q1 | $87.8M | Buy |
|
|||||
|
2014
Q4 | $19.3M | Buy |
|
|||||
|
2014
Q3 | $15M | Buy |
|
|||||
|
2014
Q2 | $999K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $1.7M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $3.46M | Buy |
|